Vyvanse 30 MG capsule 100S
Ended Awarded Last action
- Contract number
- SPE2DB26FWRN7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,643
Award facts
- Contract value 100% obligated
- $1,643.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for Vyvanse 30 mg capsules (100-count units) with a ceiling value of $1,643.39. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of October 28, 2025.
Quick answers
Who was awarded contract SPE2DB26FWRN7?
SPE2DB26FWRN7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FWRN7 worth?
The government has obligated $1,643 on SPE2DB26FWRN7.
Is contract SPE2DB26FWRN7 an order under another contract?
Yes. SPE2DB26FWRN7 is a delivery order under SPE2DB24D2018, an indefinite delivery contract.
Was contract SPE2DB26FWRN7 competed?
The extent of competition for SPE2DB26FWRN7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award